Life sciences: Multidisciplinary, general & others Microbiology
Author, co-author :
Pasero, C.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
D'Agostino, I.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
De Luca, F.; Department of Medical Biotechnology, University of Siena, Siena, I-53100, Italy
Zamperini, C.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy, Lead Discovery Siena S.r.l., Via Vittorio Alfieri 31, Castelnuovo Berardenga, I-53019, Italy
Deodato, D.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
Truglio, G. I.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
Sannio, F.; Department of Medical Biotechnology, University of Siena, Siena, I-53100, Italy
Del Prete, R.; Department of Medical Biotechnology, University of Siena, Siena, I-53100, Italy
Ferraro, T.; Lead Discovery Siena S.r.l., Via Vittorio Alfieri 31, Castelnuovo Berardenga, I-53019, Italy
Visaggio, D.; Department of Sciences, Roma Tre University, Rome, 00146, Italy
Mancini, A.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
Guglielmi, M. B.; Biogem, Research Institute, Ariano Irpino, AV, Italy
Visca, P.; Department of Sciences, Roma Tre University, Rome, 00146, Italy
Docquier, Jean-Denis ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Botta, M.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy, Lead Discovery Siena S.r.l., Via Vittorio Alfieri 31, Castelnuovo Berardenga, I-53019, Italy, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, BioLife Science Building, 1900 North 12th Street, Philadelphia, PA 19122, United States
Hughes, D.; Karlén, A. Discovery and Preclinical Development of New Antibiotics. Upsala J. Med. Sci. 2014, 119 (2), 162-169, 10.3109/03009734.2014.896437
WHO Antimicrobial Resistance. Bull. World Health Organ. 2014, 61 (3), 383-394
Fleeman, R.; Lavoi, T. M.; Santos, R. G.; Morales, A.; Nefzi, A.; Welmaker, G. S.; Medina-Franco, J. L.; Giulianotti, M. A.; Houghten, R. A.; Shaw, L. N. Combinatorial Libraries as a Tool for the Discovery of Novel, Broad-Spectrum Antibacterial Agents Targeting the ESKAPE Pathogens. J. Med. Chem. 2015, 58 (8), 3340-3355, 10.1021/jm501628s
Chellat, M. F.; Raguž, L.; Riedl, R. Targeting Antibiotic Resistance. Angew. Chem., Int. Ed. 2016, 55 (23), 6600-6626, 10.1002/anie.201506818
WHO. Global Surveillance of Antibacterial Resistance in Humans; Second WHO Technical Consultation, March, 18-19, 2014; WHO: Geneva, Switzerland.
Yarlagadda, V.; Manjunath, G. B.; Sarkar, P.; Akkapeddi, P.; Paramanandham, K.; Shome, B. R.; Ravikumar, R.; Haldar, J. Glycopeptide Antibiotic to Overcome the Intrinsic Resistance of Gram-Negative Bacteria. ACS Infect. Dis. 2016, 2 (2), 132-139, 10.1021/acsinfecdis.5b00114
Bush, K. Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check. ACS Infect. Dis. 2015, 1 (11), 509-511, 10.1021/acsinfecdis.5b00100
Zgurskaya, H. I.; López, C. A.; Gnanakaran, S. Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect. Dis. 2015, 1 (11), 512-522, 10.1021/acsinfecdis.5b00097
Rossolini, G. M.; Arena, F.; Pecile, P.; Pollini, S. Update on the Antibiotic Resistance Crisis. Curr. Opin. Pharmacol. 2014, 18, 56-60, 10.1016/j.coph.2014.09.006
Aminov, R. I. A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future. Front. Microbiol. 2010, 1, 134, 10.3389/fmicb.2010.00134
Blaskovich, M. A. T.; Zuegg, J.; Elliott, A. G.; Cooper, M. A. Helping Chemists Discover New Antibiotics. ACS Infect. Dis. 2015, 1 (7), 285-287, 10.1021/acsinfecdis.5b00044
O'Connell, K. M. G.; Hodgkinson, J. T.; Sore, H. F.; Welch, M.; Salmond, G. P. C.; Spring, D. R. Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials. Angew. Chem., Int. Ed. 2013, 52 (41), 10706-10733, 10.1002/anie.201209979
Hecker, S. J.; Reddy, K. R.; Totrov, M.; Hirst, G. C.; Lomovskaya, O.; Griffith, D. C.; King, P.; Tsivkovski, R.; Sun, D.; Sabet, M. et al. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases. J. Med. Chem. 2015, 58 (9), 3682-3692, 10.1021/acs.jmedchem.5b00127
Docquier, J.-D.; Mangani, S. An Update on β-Lactamase Inhibitor Discovery and Development. Drug Resist. Updates 2018, 36, 13-29, 10.1016/j.drup.2017.11.002
Shields, R. K.; Chen, L.; Cheng, S.; Chavda, K. D.; Press, E. G.; Snyder, A.; Pandey, R.; Doi, Y.; Kreiswirth, B. N.; Nguyen, M. H. et al. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Bornebla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infections. Antimicrob. Agents Chemother. 2017, 61 (3), 2097-2116, 10.1128/AAC.02097-16
European Centre for Disease Prevention and Control. The Bacterial Challenge-Time to React. https://ecdc.europa.eu/en/news-events/bacterial-challenge-time-react-0 (accessed Apr 20, 2018).
Wright, G. D. Solving the Antibiotic Crisis. ACS Infect. Dis. 2015, 1 (2), 80-84, 10.1021/id500052s
Wang, B.; Pachaiyappan, B.; Gruber, J. D.; Schmidt, M. G.; Zhang, Y. M.; Woster, P. M. Antibacterial Diamines Targeting Bacterial Membranes. J. Med. Chem. 2016, 59 (7), 3140-3151, 10.1021/acs.jmedchem.5b01912
Exley, S. E.; Paslay, L. C.; Sahukhal, G. S.; Abel, B. A.; Brown, T. D.; McCormick, C. L.; Heinhorst, S.; Koul, V.; Choudhary, V.; Elasri, M. O. et al. Antimicrobial Peptide Mimicking Primary Amine and Guanidine Containing Methacrylamide Copolymers Prepared by Raft Polymerization. Biomacromolecules 2015, 16 (12), 3845-3852, 10.1021/acs.biomac.5b01162
Wei, D.; Ma, Q.; Guan, Y.; Hu, F.; Zheng, A.; Zhang, X.; Teng, Z.; Jiang, H. Structural Characterization and Antibacterial Activity of Oligoguanidine (Polyhexamethylene Guanidine Hydrochloride). Mater. Sci. Eng., C 2009, 29 (6), 1776-1780, 10.1016/j.msec.2009.02.005
Burakova, E. A.; Saranina, I. V.; Tikunova, N. V.; Nazarkina, Z. K.; Laktionov, P. P.; Karpinskaya, L. A.; Anikin, V. B.; Zarubaev, V. V.; Silnikov, V. N. Biological Evaluation of Tetracationic Compounds Based on Two 1,4-Diazabicyclo[2.2.2]Octane Moieties Connected by Different Linkers. Bioorg. Med. Chem. 2016, 24 (22), 6012-6020, 10.1016/j.bmc.2016.09.064
Maccari, G.; Sanfilippo, S.; De Luca, F.; Deodato, D.; Casian, A.; Dasso Lang, M. C.; Zamperini, C.; Dreassi, E.; Rossolini, G. M.; Docquier, J. D. et al. Synthesis of Linear and Cyclic Guazatine Derivatives Endowed with Antibacterial Activity. Bioorg. Med. Chem. Lett. 2014, 24 (23), 5525-5529, 10.1016/j.bmcl.2014.09.081
Zamperini, C.; Maccari, G.; Deodato, D.; Pasero, C.; Agostino, I. D.; Orofino, F.; D'Agostino, I.; Orofino, F.; De Luca, F.; Dreassi, E. et al. Identification, Synthesis and Biological Activity of Alkyl- Guanidine Oligomers as Potent Antibacterial Agents. Sci. Rep. 2017, 7 (1), 1-11, 10.1038/s41598-017-08749-6
Asada, T.; Miura, Y.; Yoshino, T. Process for Production of 1,17-Diamino-9-azaheptadecane. Patent Appl. CA1122617 A, 27 Apr, 1982.
Zhang, Y.; Gilliam, A.; Maitra, R.; Damaj, M. I.; Tajuba, J. M.; Seltzman, H. H.; Thomas, B. F. Synthesis and Biological Evaluation of Bivalent Ligands for the Cannabinoid 1 Receptor. J. Med. Chem. 2010, 53 (19), 7048-7060, 10.1021/jm1006676
Tian, W. Q.; Wang, Y. A. Mechanisms of Staudinger Reactions within Density Functional Theory. J. Org. Chem. 2004, 69 (13), 4299-4308, 10.1021/jo049702n
Botta, M.; Maccari, G.; Sanfilippo, S.; De Luca, F.; Docquier, J. D.; Deodato, D. Linear Guanidine Derivatives, Methods of Preparation and Uses Thereof. Int. Patent Appl. WO2016/055644 A1, 14 Apr, 2016.
Cannatelli, A.; Giani, T.; D'Andrea, M. M.; Di Pilato, V.; Arena, F.; Conte, V.; Tryfinopoulou, K.; Vatopoulos, A.; Rossolini, G. M. COLGRIT Study Group. MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella Pneumoniae of Clinical Origin. Antimicrob. Agents Chemother. 2014, 58 (10), 5696-5703, 10.1128/AAC.03110-14
Choi, S.; Choi, E. Y.; Kim, D. J.; Kim, J. H.; Kim, T. S.; Oh, S. W. A Rapid, Simple Measurement of Human Albumin in Whole Blood Using a Fluorescence Immunoassay (I). Clin. Chim. Acta 2004, 339 (1-2), 147-156, 10.1016/j.cccn.2003.10.002
Goncharova, I.; Orlov, S.; Urbanová, M. The Location of the High- and Low-Affinity Bilirubin-Binding Sites on Serum Albumin: Ligand-Competition Analysis Investigated by Circular Dichroism. Biophys. Chem. 2013, 180-181, 55-65, 10.1016/j.bpc.2013.06.004
Silvestro, L.; Weiser, J. N.; Axelsen, P. H. Antibacterial and Antimembrane Activities of Cecropin A in Escherichia Coli. Antimicrob. Agents Chemother. 2000, 44 (3), 602-607, 10.1128/AAC.44.3.602-607.2000
Lehrer, R. I.; Barton, A.; Daher, K. A.; Harwig, S. S.; Ganz, T.; Selsted, M. E. Interaction of Human Defensins with Escherichia Coli. Mechanism of Bactericidal Activity. J. Clin. Invest. 1989, 84 (2), 553-561, 10.1172/JCI114198
Loh, B.; Grant, C.; Hancock, R. E. Use of the Fluorescent Probe 1-N-Phenylnaphthylamine to Study the Interactions of Aminoglycoside Antibiotics with the Outer Membrane of Pseudomonas Aeruginosa. Antimicrob. Agents Chemother. 1984, 26 (4), 546-551, 10.1128/AAC.26.4.546
Breeuwer, P.; Abee, T. Assessment of Viability of Microorganisms Employing Fluorescence Techniques. Int. J. Food Microbiol. 2000, 55 (1-3), 193-200, 10.1016/S0168-1605(00)00163-X
Li, X.-H.; Lee, J.-H. Antibiofilm Agents: A New Perspective for Antimicrobial Strategy. J. Microbiol. 2017, 55 (10), 753-766, 10.1007/s12275-017-7274-x
Roy, R.; Tiwari, M.; Donelli, G.; Tiwari, V. Strategies for Combating Bacterial Biofilms: A Focus on Anti-Biofilm Agents and Their Mechanisms of Action. Virulence 2018, 9 (1), 522-554, 10.1080/21505594.2017.1313372
Li, P.; Wohland, T.; Ho, B.; Ding, J. L. Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) Antimicrobial Peptide. The Importance of an Intermolecular Disulfide Bond in S3 Dimer for Binding, Disruption, and Neutralization of LPS. J. Biol. Chem. 2004, 279 (48), 50150-50156, 10.1074/jbc.M405606200
Raffi, F.; Corelli, F.; Botta, M. Efficient Synthesis of Iminoctadine, a Potent Antifungal Agent and Polyamine Oxidase Inhibitor (PAO). Synthesis 2007, 2007, 3013-3016, 10.1055/s-2007-983898
Uemura, T.; Gerner, E. W. Polyamine Transport Systems in Mammalian Cells and Tissues. Methods Mol. Biol. 2011, 720, 339-348, 10.1007/978-1-61779-034-8-21
Igarashi, K.; Ito, K.; Kashiwagi, K. Polyamine Uptake Systems in Escherichia coli. Res. Microbiol. 2001, 152 (3-4), 271-278, 10.1016/S0923-2508(01)01198-6
Baba, T.; Ara, T.; Hasegawa, M.; Takai, Y.; Okumura, Y.; Baba, M.; Datsenko, K. A.; Tomita, M.; Wanner, B. L.; Mori, H. Construction of Escherichia Coli K-12 in-Frame, Single-Gene Knockout Mutants: The Keio Collection. Mol. Syst. Biol. 2006, 2 (1), 2006.0008, 10.1038/msb4100050
Jin, Y.; Hammer, J.; Pate, M.; Zhang, Y.; Zhu, F.; Zmuda, E.; Blazyk, J. Antimicrobial Activities and Structures of Two Linear Cationic Peptide Families with Various Amphipathic -Sheet and -Helical Potentials. Antimicrob. Agents Chemother. 2005, 49 (12), 4957-4964, 10.1128/AAC.49.12.4957-4964.2005
Weisiger, R. A. Dissociation from Albumin: A Potentially Rate-Limiting Step in the Clearance of Substances by the Liver. Proc. Natl. Acad. Sci. U. S. A. 1985, 82 (5), 1563-1567, 10.1073/pnas.82.5.1563
Robinson, P. J.; Rapoport, S. I. Kinetics of Protein Binding Determine Rates of Uptake of Drugs by Brain. Am. J. Physiol. Integr. Comp. Physiol. 1986, 251 (6), R1212-R1220, 10.1152/ajpregu.1986.251.6.R1212
Kerns, E. H.; Di, L. Drug-Like Properties: Concepts, Structure Design and Methods: From ADME to Toxicity Optimization; Academic Press: San Diego, CA, 2008.
Kansy, M.; Senner, F.; Gubernator, K. Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes. J. Med. Chem. 1998, 41 (7), 1007-1010, 10.1021/jm970530e
Cova, E.; Laforenza, U.; Gastaldi, G.; Sambuy, Y.; Tritto, S.; Faelli, A.; Ventura, U. Guanidine Transport across the Apical and Basolateral Membranes of Human Intestinal Caco-2 Cells Is Mediated by Two Different Mechanisms. J. Nutr. 2002, 132 (7), 1995-2003, 10.1093/jn/132.7.1995
Gründemann, D.; Gorboulev, V.; Gambaryan, S.; Veyhl, M.; Koepsell, H. Drug Excretion Mediated by a New Prototype of Polyspecific Transporter. Nature 1994, 372 (6506), 549-552, 10.1038/372549a0
Wu, X.; Prasad, P. D.; Leibach, F. H.; Ganapathy, V. CDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter Family. Biochem. Biophys. Res. Commun. 1998, 246 (3), 589-595, 10.1006/bbrc.1998.8669
Artursson, P.; Palm, K.; Luthman, K. Caco-2 Monolayers in Experimental and Theoretical Predictions of Drug Transport. Adv. Drug Delivery Rev. 2001, 46 (1-3), 27-43, 10.1016/S0169-409X(00)00128-9
Balimane, P. V.; Patel, K.; Marino, A.; Chong, S. Utility of 96 Well Caco-2 Cell System for Increased Throughput of P-Gp Screening in Drug Discovery. Eur. J. Pharm. Biopharm. 2004, 58 (1), 99-105, 10.1016/j.ejpb.2004.02.014
Peterman, S. M.; Duczak, N.; Kalgutkar, A. S.; Lame, M. E.; Soglia, J. R. Application of a Linear Ion Trap/Orbitrap Mass Spectrometer in Metabolite Characterization Studies: Examination of the Human Liver Microsomal Metabolism of the Non-Tricyclic Anti-Depressant Nefazodone Using Data-Dependent Accurate Mass Measurements. J. Am. Soc. Mass Spectrom. 2006, 17 (3), 363-375, 10.1016/j.jasms.2005.11.014
Yu, L. X.; Amidon, G. L.; Polli, J. E.; Zhao, H.; Mehta, M. U.; Conner, D. P.; Shah, V. P.; Lesko, L. J.; Chen, M.-L.; Lee, V. H. L.; Hussain, A. S. Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions. Pharm. Res. 2002, 19 (7), 921-925, 10.1023/A:1016473601633
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Colistimethate for Injection USP, ANDA 64-216 Approval Letter, Feb 26, 1991. https://www.accessdata.fda.gov/drugsatfda-docs/anda/99/064216Orig1s000.pdf (accessed Jul 14, 2018).
Kerns, E. H.; Di, L. I.; Petusky, S.; Farris, M.; Ley, R.; Jupp, P. Combined Application of Parallel Artificial Membrane Permeability Assay and Caco-2 Permeability Assays in Drug Discovery. J. Pharm. Sci. 2004, 93 (6), 1440-1453, 10.1002/jps.20075
Takenaka, T.; Harada, N.; Kuze, J.; Chiba, M.; Iwao, T.; Matsunaga, T. Human Small Intestinal Epithelial Cells Differentiated from Adult Intestinal Stem Cells as a Novel System for Predicting Oral Drug Absorption in Humans. Drug Metab. Dispos. 2014, 42 (11), 1947-1954, 10.1124/dmd.114.059493
Riccio, M. L.; Franceschini, N.; Boschi, L.; Caravelli, B.; Cornaglia, G.; Fontana, R.; Amicosante, G.; Rossolini, G. M. Characterization of the Metallo-Beta-Lactamase Determinant of Acinetobacter Baumannii AC-54/97 Reveals the Existence of Bla(IMP) Allelic Variants Carried by Gene Cassettes of Different Phylogeny. Antimicrob. Agents Chemother. 2000, 44 (5), 1229-1235, 10.1128/AAC.44.5.1229-1235.2000
Luzzaro, F.; Docquier, J.-D.; Colinon, C.; Endimiani, A.; Lombardi, G.; Amicosante, G.; Rossolini, G. M.; Toniolo, A. Emergence in Klebsiella Pneumoniae and Enterobacter Cloacae Clinical Isolates of the VIM-4 Metallo-Beta-Lactamase Encoded by a Conjugative Plasmid. Antimicrob. Agents Chemother. 2004, 48 (2), 648-650, 10.1128/AAC.48.2.648-650.2004
CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 9 th ed.; CLSI document M07-A9; Clinical and Laboratory Standards Institute: Wayne, PA, 2012; 32.
Runci, F.; Bonchi, C.; Frangipani, E.; Visaggio, D.; Visca, P. Acinetobacter Baumannii Biofilm Formation in Human Serum and Disruption by Gallium. Antimicrob. Agents Chemother. 2017, 61 (1), e01563-16, 10.1128/AAC.01563-16
Lehrer, R. I.; Barton, A.; Ganz, T. Concurrent Assessment of Inner and Outer Membrane Permeabilization and Bacteriolysis in E. Coli by Multiple-Wavelength Spectrophotometry. J. Immunol. Methods 1988, 108 (1-2), 153-158, 10.1016/0022-1759(88)90414-0
Chusri, S.; Villanueva, I.; Voravuthikunchai, S. P.; Davies, J. Enhancing Antibiotic Activity: A Strategy to Control Acinetobacter Infections. J. Antimicrob. Chemother. 2009, 64 (6), 1203-1211, 10.1093/jac/dkp381
Lagorce, D.; Sperandio, O.; Baell, J. B.; Miteva, M. A.; Villoutreix, B. O. FAF-Drugs3: A Web Server for Compound Property Calculation and Chemical Library Design. Nucleic Acids Res. 2015, 43 (W1), W200-W207, 10.1093/nar/gkv353
Lagorce, D.; Sperandio, O.; Galons, H.; Miteva, M. A.; Villoutreix, B. O. FAF-Drugs2: Free ADME/Tox Filtering Tool to Assist Drug Discovery and Chemical Biology Projects. BMC Bioinf. 2008, 9 (1), 396, 10.1186/1471-2105-9-396
Baell, J. B.; Holloway, G. A. New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. J. Med. Chem. 2010, 53 (7), 2719-2740, 10.1021/jm901137j
Parikh, H. H.; McElwain, K.; Balasubramanian, V.; Leung, W.; Wong, D.; Morris, M. E.; Ramanathan, M. A Rapid Spectrofluorimetric Technique for Determining Drug-Serum Protein Binding Suitable for High-Throughput Screening. Pharm. Res. 2000, 17 (5), 632-637, 10.1023/A:1007537520620
Huang, J. X.; Cooper, M. A.; Baker, M. A.; Azad, M. A. K.; Nation, R. L.; Li, J.; Velkov, T. Drug-Binding Energetics of Human α-1-Acid Glycoprotein Assessed by Isothermal Titration Calorimetry and Molecular Docking Simulations. J. Mol. Recognit. 2012, 25 (12), 642-656, 10.1002/jmr.2221
Wohnsland, F.; Faller, B. High-Throughput Permeability PH Profile and High-Throughput Alkane/Water Log P with Artificial Membranes. J. Med. Chem. 2001, 44 (6), 923-930, 10.1021/jm001020e
